Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
zuclopenthixol alpha-1a adrenergic receptor small molecule NA drugbank Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Manic[MeSHID:D001714]
Psychotic Disorders[MeSHID:D011618]
Behavior[MeSHID:D001519]
Emergencies [Disease/Finding][MeSHID:D004630]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved,investigational antagonist
zuclopenthixol alpha-2a adrenergic receptor small molecule NA drugbank Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Manic[MeSHID:D001714]
Psychotic Disorders[MeSHID:D011618]
Behavior[MeSHID:D001519]
Emergencies [Disease/Finding][MeSHID:D004630]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved,investigational antagonist
zuclopenthixol dopamine d1 receptor small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Manic[MeSHID:D001714]
Psychotic Disorders[MeSHID:D011618]
Behavior[MeSHID:D001519]
Emergencies [Disease/Finding][MeSHID:D004630]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.31 approved,investigational antagonist
zuclopenthixol dopamine d2 receptor small molecule Successful target TTD , drugbank , DGIDB Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Manic[MeSHID:D001714]
Psychotic Disorders[MeSHID:D011618]
Behavior[MeSHID:D001519]
Emergencies [Disease/Finding][MeSHID:D004630]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
0.5 approved,investigational antagonist
zuclopenthixol dopamine d5 receptor small molecule NA drugbank , DGIDB Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Manic[MeSHID:D001714]
Psychotic Disorders[MeSHID:D011618]
Behavior[MeSHID:D001519]
Emergencies [Disease/Finding][MeSHID:D004630]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
1.59 approved,investigational antagonist
zuclopenthixol histamine h1 receptor small molecule NA drugbank Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Manic[MeSHID:D001714]
Psychotic Disorders[MeSHID:D011618]
Behavior[MeSHID:D001519]
Emergencies [Disease/Finding][MeSHID:D004630]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved,investigational antagonist
zuclopenthixol 5-hydroxytryptamine receptor 2a small molecule NA drugbank Disease Management[MeSHID:D019468]
Schizophrenia[MeSHID:D012559]
Manic[MeSHID:D001714]
Psychotic Disorders[MeSHID:D011618]
Behavior[MeSHID:D001519]
Emergencies [Disease/Finding][MeSHID:D004630]
Term Birth[MeSHID:D047929]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
NA approved,investigational antagonist
click here to return to the previous page